Center-Authored Papers

Filters: Keyword is Receptor, erbB-2  [Clear All Filters]
A
C
D
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, Malone KE.  2009.  Risk factors for triple-negative breast cancer in women under the age of 45 years.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(4):1157-66. Abstract
F
G
H
J
Jhaveri K, Linden H.  2015.  Measuring tumor metabolism by 18F-FDG PET predicts outcome in a multicenter study: a step off in the right direction.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 56(1):1-2.
L
M
P
Phipps AI, Chlebowski RT, Prentice RL, McTiernan A, Stefanick ML, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Vitolins M et al..  2011.  Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(3):454-63. Abstract
Phipps AI, Malone KE, Porter PL, Daling JR, Li CI.  2008.  Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(8):2078-86. Abstract